CNTNAP2 and neurodevelopmental disorder: In this study, we show that the field of brain organoid modeling holds great promise for working towards a preclinical modeling system with face validity, with the ultimate goal of creating targeted treatments that may eventually improve the lives of patients with severe neurodevelopmental disorders such as CNTNAP2-associated ASD.